Mylan rises as 2Q results beat estimates
News | 26 July 2012
Mylan, one of the world's largest makers of generic drugs, reported strong sales of its generics as well as strong sales of EpiPen in the U.S. EpiPen is a pre-filled syringe used to treat severe allergic reactions. It is made by Pfizer Inc., and Mylan ...
Click on the link to read the full article at Businessweek
(This link will open in a new window)
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
